AvKARE is voluntarily recalling one lot of Amantadine HCl (100 mg) capsules, a medication used to treat Parkinson's disease and certain viral infections. The recall was issued because the drug failed dissolution testing, which means the capsules may not dissolve properly in the body as intended. Consumers who have this medication should check their packaging for the specific lot number and expiration date listed below. If you are taking this medication, contact your healthcare provider or pharmacist to discuss your treatment and how to obtain a replacement.
If the medication does not dissolve correctly, the body may not absorb the necessary amount of the active ingredient, potentially making the treatment less effective for managing symptoms or infections.
You have 2 options:
Recall #: D-0341-2026; UPS specifications
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.